Physician profile
Brian Firestone
NPI 1073772398
$1,243.90
in general payments reported to CMS, 2019-2025
16 companies · $674 in 2025
The $674 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.38 · 2021: $35.98 · 2023: $114 · 2024: $406 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $316.05 | 2023-2024 | Iluvien, Yutiq |
| Apellis Pharmaceuticals, INC. | $269.78 | 2024-2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $150.18 | 2025 | Iluvien, Yutiq, Purified Cortrophin Gel |
| Regeneron Healthcare Solutions, INC. | $124.03 | 2025 | Eylea Hd |
| Abbvie INC. | $80.17 | 2025 | |
| Astellas Pharma US INC | $56.00 | 2024-2025 | Izervay |
| Amgen INC. | $37.79 | 2025 | Tepezza |
| Delcath Systems | $33.93 | 2025 | Hepzato Kit |
| Genentech USA, INC. | $30.69 | 2025 | Vabysmo |
| Immunocore Limited | $29.92 | 2025 | Kimmtrak |
| Alcon Vision LLC | $24.86 | 2023 | Centurion |
| Eyepoint US, INC. | $23.79 | 2021 | |
| Thea Pharma INC. | $21.77 | 2024 | Iyuzeh |
| Ocular Therapeutix, INC. | $18.37 | 2025 | Dextenza |
| Novartis Pharmaceuticals Corporation | $14.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Firestone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.